{"id":"levitra","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Headache","drugRate":"15%","severity":"common","organSystem":""},{"effect":"Flushing","drugRate":"11%","severity":"common","organSystem":""},{"effect":"Rhinitis","drugRate":"9%","severity":"common","organSystem":""},{"effect":"Dyspepsia","drugRate":"4%","severity":"common","organSystem":""},{"effect":"Accidental Injury","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Sinusitis","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Flu Syndrome","drugRate":"3%","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Increased Creatine Kinase","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"2%","severity":"common","organSystem":""},{"effect":"Back pain","drugRate":"2%","severity":"common","organSystem":""}],"contraindications":["Acute coronary syndrome","Acute nephropathy","Acute peptic ulcer","Anterior ischemic optic neuropathy","Aortic valve stenosis","Blood coagulation disorder","Cerebrovascular accident","Chronic heart failure","Congenital long QT syndrome","Fibrosis of corpus cavernosum","Hb SS disease","Hearing loss","Hepatic failure","Hypertensive urgency","Idiopathic hypertrophic subaortic stenosis","Induratio penis plastica","Leukemia, disease","Life-Threatening Cardiac Arrhythmias","Low blood pressure","Multiple myeloma","Myocardial infarction","Penis bent","Pigmentary Retinopathy","Priapism"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Myocardial infarction","drugRate":"","severity":"serious"},{"effect":"Myocardial ischemia","drugRate":"","severity":"serious"},{"effect":"Angina pectoris","drugRate":"","severity":"serious"},{"effect":"Syncope","drugRate":"","severity":"serious"},{"effect":"Anaphylactic reaction","drugRate":"","severity":"serious"},{"effect":"Priapism","drugRate":"","severity":"serious"},{"effect":"Sudden decrease or loss of hearing","drugRate":"","severity":"serious"},{"effect":"Laryngeal edema","drugRate":"","severity":"serious"},{"effect":"Glaucoma","drugRate":"","severity":"serious"},{"effect":"Dysphagia","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Levitra","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:40:44.422408+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:40:52.590634+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Levitra","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:40:52.925637+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Phosphodiesterase 5A inhibitor","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:40:54.111327+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1339/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:40:53.630685+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"34c30372-08b0-4060-8aba-779b5bc1e5dd","title":"LEVITRA (VARDENAFIL HYDROCHLORIDE) TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, INC.]"},"ecosystem":[],"mechanism":{"target":"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A"},"_scrapedAt":"2026-03-27T23:33:57.665Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:40:55.513425+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Impotence","diseaseId":"impotence","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05567367","phase":"PHASE1","title":"A Healthy Volunteer Study Evaluating the the Safety, Tolerability, and Pharmacokinetics of RT234","status":"COMPLETED","sponsor":"Respira Therapeutics, Inc.","startDate":"2018-07-31","conditions":"Healthy Volunteer","enrollment":31},{"nctId":"NCT06860399","phase":"PHASE1, PHASE2","title":"Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn","status":"COMPLETED","sponsor":"Damascus University","startDate":"2023-05-01","conditions":"PPHN","enrollment":55},{"nctId":"NCT06491108","phase":"PHASE3","title":"Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia","status":"RECRUITING","sponsor":"Tanta University","startDate":"2024-06-01","conditions":"Enlarged Prostate With Lower Urinary Tract Symptoms","enrollment":150},{"nctId":"NCT05343637","phase":"PHASE2","title":"A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Respira Therapeutics, Inc.","startDate":"2019-07-30","conditions":"Pulmonary Arterial Hypertension","enrollment":14},{"nctId":"NCT01084369","phase":"PHASE4","title":"Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism","status":"TERMINATED","sponsor":"Tameside Hospital NHS Foundation Trust","startDate":"2013-10-11","conditions":"Type 2 Diabetes, Hypogonadism","enrollment":22},{"nctId":"NCT01002534","phase":"PHASE2","title":"Does a Nasal Instillation of Vardenafil Normalize the Nasal Potential Difference in Cystic Fibrosis Patients?","status":"TERMINATED","sponsor":"Cliniques universitaires Saint-Luc- Université Catholique de Louvain","startDate":"2011-10","conditions":"Cystic Fibrosis","enrollment":5},{"nctId":"NCT00867815","phase":"PHASE4","title":"PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)","status":"TERMINATED","sponsor":"Bayer","startDate":"2009-07-13","conditions":"Anterior Ischemic Optic Neuropathy","enrollment":10},{"nctId":"NCT02450188","phase":"PHASE4","title":"Vardenafil and Cognitive-behavioral Sex Therapy for the Treatment of Erectile Dysfunction (STEDOV)","status":"COMPLETED","sponsor":"University of Florence","startDate":"2012-03","conditions":"Erectile Dysfunction","enrollment":30},{"nctId":"NCT01131104","phase":"","title":"A Study to Determine if There is a Possible Association Between NAION and Phosphodiesterase Type 5 (PDE5) Inhibitors","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2010-05","conditions":"Nonarteritic Anterior Ischemic Optic Neuropathy","enrollment":345},{"nctId":"NCT03102398","phase":"PHASE1, PHASE2","title":"A Study to Assess the Safety and Tolerability Profile of TR399 in Healthy Volunteers and Erectile Dysfunction Patients","status":"UNKNOWN","sponsor":"Tritech Biopharmaceuticals Co., Ltd.","startDate":"2017-03-31","conditions":"Erectile Dysfunction","enrollment":26},{"nctId":"NCT02279992","phase":"EARLY_PHASE1","title":"Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases","status":"TERMINATED","sponsor":"Cedars-Sinai Medical Center","startDate":"2012-03-27","conditions":"Glioma, Brain Neoplasms, Brain Metastasis","enrollment":7},{"nctId":"NCT00379756","phase":"PHASE4","title":"A Study Evaluating Vardenafil Compared to Placebo in Subjects With Erectile Dysfunction (ED) and Dyslipidemia","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-05-22","conditions":"Erectile Dysfunction","enrollment":395},{"nctId":"NCT01106118","phase":"","title":"Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-01","conditions":"Erectile Dysfunction","enrollment":2289},{"nctId":"NCT00738400","phase":"PHASE4","title":"Study of Vardenafil in Patients Suffering From Erectile Dysfunction and Metabolic Syndrome","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-11","conditions":"Erectile Dysfunction, Metabolic Syndrome","enrollment":150},{"nctId":"NCT02344823","phase":"PHASE4","title":"Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2012-06","conditions":"Cirrhosis, Erectile Dysfunction","enrollment":30},{"nctId":"NCT00667966","phase":"PHASE4","title":"Assess Efficacy in Subjects With Traumatic Spinal Cord Injury","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-07","conditions":"Erectile Dysfunction, Spinal Cord Injury","enrollment":45},{"nctId":"NCT00461565","phase":"PHASE4","title":"FDA Phase IV - Commitment - Retinal Function Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-02","conditions":"Safety","enrollment":63},{"nctId":"NCT00668057","phase":"PHASE3","title":"BAY38-9456 (Vardenafil HCL Tablet) in ED Treatment for China Registration.","status":"COMPLETED","sponsor":"Bayer","startDate":"2002-12","conditions":"Erectile Dysfunction","enrollment":624},{"nctId":"NCT01207947","phase":"","title":"LEVITRA® Specific Drug Use Investigation. To Investigate the Safety Profile in Combination Use With Alpha-blockers","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-10","conditions":"Erectile Dysfunction","enrollment":491},{"nctId":"NCT00663728","phase":"PHASE4","title":"Assessment of Duration of Erection With Vardenafil 10 mg","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-09","conditions":"Erectile Dysfunction","enrollment":201},{"nctId":"NCT00631969","phase":"PHASE3","title":"Vardenafil ODT Versus Placebo in Males With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-04","conditions":"Erectile Dysfunction","enrollment":362},{"nctId":"NCT00661596","phase":"PHASE3","title":"Assessment of Efficacy of Vardenafil, Influence on Self-esteem and Self-confidence in Subjects With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-05","conditions":"Erectile Dysfunction","enrollment":129},{"nctId":"NCT00655590","phase":"PHASE4","title":"Assess the Effect of Daily Treatment of Vardenafil 20mg or Sildenafil 100mg and Placebo on Sperm Function","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-01","conditions":"Erectile Dysfunction","enrollment":200},{"nctId":"NCT00665054","phase":"PHASE4","title":"BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-08","conditions":"Erectile Dysfunction","enrollment":160},{"nctId":"NCT00657644","phase":"PHASE3","title":"Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-08","conditions":"Erectile Dysfunction","enrollment":130},{"nctId":"NCT00668096","phase":"PHASE4","title":"A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-05","conditions":"Erectile Dysfunction","enrollment":260},{"nctId":"NCT00377793","phase":"PHASE4","title":"Levitra (Vardenafil, BAY38-9456) Partner Satisfaction Study II","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-07","conditions":"Sexual Dysfunction, Male Erectile Dysfunction","enrollment":352},{"nctId":"NCT00668018","phase":"PHASE3","title":"Assess Efficacy of Vardenafil 10mg in Erectile Dysfunction Within Intake of 6 Hours","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-01","conditions":"Erectile Dysfunction","enrollment":887},{"nctId":"NCT00661219","phase":"PHASE3","title":"Depression Related Improvement With Vardenafil for Erectile Response","status":"COMPLETED","sponsor":"Bayer","startDate":"2002-12","conditions":"Erectile Dysfunction, Depression","enrollment":280},{"nctId":"NCT00652262","phase":"PHASE3","title":"BAY38-9456 - Supportive Trial for Spinal Injury","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-03","conditions":"Erectile Dysfunction, Sexual Dysfunction, Spinal Cord Injury","enrollment":32},{"nctId":"NCT00668109","phase":"PHASE3","title":"Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-12","conditions":"Erectile Dysfunction","enrollment":614},{"nctId":"NCT00654914","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-05","conditions":"Erectile Dysfunction","enrollment":527},{"nctId":"NCT00461123","phase":"PHASE2","title":"Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-03","conditions":"Prostatic Hypertrophy, Benign","enrollment":50},{"nctId":"NCT00678704","phase":"PHASE3","title":"BAY38-9456 - Pivotal Trial for Diabetes Patient","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-01","conditions":"Erectile Dysfunction, Diabetes Mellitus","enrollment":790},{"nctId":"NCT00663598","phase":"PHASE4","title":"Levitra® - Real Life Safety and Efficacy of Levitra","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-10","conditions":"Erectile Dysfunction","enrollment":30825},{"nctId":"NCT00668135","phase":"PHASE4","title":"Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-03","conditions":"Erectile Dysfunction","enrollment":348},{"nctId":"NCT00665496","phase":"PHASE3","title":"A Study to Investigate the Time to Onset of Action of 10 mg and 20 mg of Vardenafil Compared to Placebo in Males With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-06","conditions":"Erectile Dysfunction","enrollment":732},{"nctId":"NCT00661115","phase":"PHASE3","title":"To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-05","conditions":"Erectile Dysfunction","enrollment":173},{"nctId":"NCT00668005","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction and Hypertension","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-02","conditions":"Erectile Dysfunction","enrollment":388},{"nctId":"NCT00909233","phase":"","title":"LEVITRA® 20mg Special Drug Use Investigation (Long-term)","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-08","conditions":"Erectile Dysfunction","enrollment":1221},{"nctId":"NCT00478881","phase":"PHASE2","title":"A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-08","conditions":"Overactive Bladder, Detrusor Overactivity","enrollment":397},{"nctId":"NCT00660998","phase":"PHASE4","title":"Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 Diabetes","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-02","conditions":"Erectile Dysfunction","enrollment":318},{"nctId":"NCT00681772","phase":"PHASE4","title":"Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-03","conditions":"Erectile Dysfunction","enrollment":333},{"nctId":"NCT00664833","phase":"PHASE4","title":"Evaluation of LEVITRA to Advance the Treatment of Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-05","conditions":"Erectile Dysfunction","enrollment":1029},{"nctId":"NCT00666809","phase":"PHASE2","title":"Vardenafil in Tinnitus","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-10","conditions":"Tinnitus","enrollment":43},{"nctId":"NCT00470873","phase":"","title":"Vardenafil Treatment Of Erectile Dysfunction In Depressive And Non-Depressive Men","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-01","conditions":"Erectile Dysfunction","enrollment":2471},{"nctId":"NCT00658177","phase":"PHASE3","title":"Study Evaluating the Efficacy and Safety of Flexible-dose Vardenafil in Subjects With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-06","conditions":"Erectile Dysfunction","enrollment":463},{"nctId":"NCT00661297","phase":"PHASE3","title":"Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-06","conditions":"Erectile Dysfunction","enrollment":523},{"nctId":"NCT00661700","phase":"PHASE3","title":"A Double-blind \"Preferred\" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-04","conditions":"Erectile Dysfunction","enrollment":611},{"nctId":"NCT01168817","phase":"PHASE2","title":"Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-08","conditions":"Erectile Dysfunction","enrollment":140},{"nctId":"NCT00657839","phase":"PHASE2","title":"Assessment of Efficacy of Vardenafil in the Treatment of Subjects With Symptomatic Benign Prostatic Hyperplasia","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-10","conditions":"Benign Prostatic Hyperplasia","enrollment":222},{"nctId":"NCT00786253","phase":"PHASE2","title":"Sustainable Efficacy of Vardenafil OD Versus Vardenafil PRN in Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2005-10","conditions":"Erectile Dysfunction","enrollment":236},{"nctId":"NCT00492635","phase":"PHASE3","title":"Study to Compare the Tolerability and Efficacy of Once Daily Vardenafil vs Vardenafil PRN vs Placebo in Men Immediately After Nerve-sparing Prostatectomy for Improving ED","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-12","conditions":"Erectile Dysfunction, Sexual Dysfunction, Physiological","enrollment":628},{"nctId":"NCT02219646","phase":"PHASE2","title":"Diabetes & Vardenafil","status":"COMPLETED","sponsor":"Azienda USL Modena","startDate":"2010-03","conditions":"Type 2 Diabetes Mellitus (T2DM), Endothelial Dysfunction, Erectile Dysfunction","enrollment":54},{"nctId":"NCT00655629","phase":"PHASE3","title":"Vardenafil Orodispersible Tablet (ODT) Versus Placebo in Males With Erectile Dysfunction, 50% of Whom Are to be 65 Years or Older.","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-04","conditions":"Erectile Dysfunction","enrollment":339},{"nctId":"NCT01348880","phase":"PHASE1","title":"Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-05","conditions":"Erectile Dysfunction","enrollment":42},{"nctId":"NCT01215409","phase":"","title":"Real Life Safety and Efficacy of Vardenafil","status":"TERMINATED","sponsor":"Bayer","startDate":"2008-02","conditions":"Erectile Dysfunction","enrollment":372},{"nctId":"NCT00657033","phase":"PHASE3","title":"Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-10","conditions":"Erectile Dysfunction","enrollment":229},{"nctId":"NCT00682019","phase":"PHASE3","title":"Study Evaluation the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction for 10 Weeks","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-12","conditions":"Erectile Dysfunction","enrollment":383},{"nctId":"NCT00663845","phase":"PHASE4","title":"Assessing Efficacy and Safety of Flexible Dosing With Vardenafil in Subjects With Erectile Dysfunction and Hyperlipidemia","status":"COMPLETED","sponsor":"Bayer","startDate":"2006-05","conditions":"Erectile Dysfunction","enrollment":395},{"nctId":"NCT00665340","phase":"PHASE4","title":"Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-07","conditions":"Erectile Dysfunction","enrollment":219},{"nctId":"NCT00663130","phase":"PHASE4","title":"Evaluating the Efficacy Vardenafil 10 mg vs Tadalafil 10 mg in in Subjects With Erectile Dysfunction (ED)","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-04","conditions":"Erectile Dysfunction","enrollment":759},{"nctId":"NCT00656188","phase":"PHASE2, PHASE3","title":"Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2002-10","conditions":"Erectile Dysfunction","enrollment":463},{"nctId":"NCT00654680","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury","status":"COMPLETED","sponsor":"Bayer","startDate":"2002-10","conditions":"Erectile Dysfunction","enrollment":418},{"nctId":"NCT01110590","phase":"PHASE1","title":"Multiple Dose Escalation Study (14 Days) to Investigate Safety, Tolerability, PK and PD of Vardenafil and BAY60-4552","status":"COMPLETED","sponsor":"Bayer","startDate":"2010-01","conditions":"Erectile Dysfunction","enrollment":37},{"nctId":"NCT00853840","phase":"PHASE4","title":"Study To Investigate The Hemodynamic Effects Of Single Dose Vardenafil In Subjects Receiving Maraviroc","status":"COMPLETED","sponsor":"ViiV Healthcare","startDate":"2008-04","conditions":"AIDS","enrollment":18},{"nctId":"NCT01063855","phase":"PHASE3","title":"Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2010-04","conditions":"Erectile Dysfunction, Sexual Dysfunction","enrollment":495},{"nctId":"NCT01649739","phase":"PHASE4","title":"Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled Iloprost","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2012-09","conditions":"Pulmonary Arterial Hypertension","enrollment":20},{"nctId":"NCT00874679","phase":"","title":"REPEAT - Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra Therapy","status":"COMPLETED","sponsor":"Bayer","startDate":"2007-03","conditions":"Erectile Dysfunction","enrollment":7293},{"nctId":"NCT01260285","phase":"PHASE1","title":"The Safety of Vardenafil in Patients Undergoing Cardiac Surgery","status":"COMPLETED","sponsor":"McGuire Research Institute","startDate":"2010-12","conditions":"Ischemia-reperfusion Injury.","enrollment":10},{"nctId":"NCT01406535","phase":"","title":"Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery Disease","status":"TEMPORARILY_NOT_AVAILABLE","sponsor":"Medical University of Vienna","startDate":"","conditions":"Therapy Refractory Myocardial Ischemia, Coronary Artery Disease, Unsuitable for Surgical or Percutaneous Revascularisation","enrollment":""},{"nctId":"NCT00517179","phase":"NA","title":"Effect of Vardenafil on Blood Pressure in Patients With Erectile Dysfunction Who Received Concomitant Doxazosin GITS","status":"COMPLETED","sponsor":"Hospital Authority, Hong Kong","startDate":"2006-04","conditions":"Prostatic Hyperplasia, Impotence","enrollment":40},{"nctId":"NCT01084187","phase":"PHASE4","title":"Correlation Study of Vascular Parameters in Hypertensive Men With Erectile Dysfunction","status":"COMPLETED","sponsor":"Hospital Universitario Pedro Ernesto","startDate":"2010-01","conditions":"Erectile Dysfunction, Arterial Hypertension, Endothelial Dysfunction","enrollment":100},{"nctId":"NCT01291199","phase":"PHASE2, PHASE3","title":"Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2006-11","conditions":"Raynaud Syndrome","enrollment":57},{"nctId":"NCT00498680","phase":"PHASE4","title":"Safety and Clinical Effectiveness of 2 Lower Dose Combined PDE5i's vs. Single Maximal Dose PDE5i","status":"UNKNOWN","sponsor":"Rambam Health Care Campus","startDate":"2007-03","conditions":"Impotence","enrollment":46},{"nctId":"NCT00718952","phase":"PHASE3","title":"The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Tongji University","startDate":"2008-07","conditions":"Pulmonary Hypertension","enrollment":60},{"nctId":"NCT00667979","phase":"PHASE4","title":"Evaluating the Efficacy of Vardenafil in Subjects With Erectile Dysfunction (ED) Administered 12, 18 or 24 Hours Prior to Intercourse","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-09","conditions":"Erectile Dysfunction","enrollment":264},{"nctId":"NCT00662441","phase":"PHASE4","title":"Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction","status":"COMPLETED","sponsor":"Bayer","startDate":"2003-09","conditions":"Erectile Dysfunction","enrollment":102},{"nctId":"NCT00767598","phase":"PHASE1","title":"The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects","status":"COMPLETED","sponsor":"Inje University","startDate":"2007-12","conditions":"Pharmacokinetics of Three PDE5Is, Healthy Subjects, Genetic Polymorphic CYP3A5","enrollment":21},{"nctId":"NCT00725790","phase":"PHASE4","title":"A Study to Evaluate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction Caused by Spinal Cord Injury","status":"UNKNOWN","sponsor":"China Rehabilitation Research Center","startDate":"2008-08","conditions":"Erectile Dysfunction","enrollment":350},{"nctId":"NCT00705588","phase":"PHASE4","title":"Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.","status":"UNKNOWN","sponsor":"Rabin Medical Center","startDate":"2008-08","conditions":"Pulmonary Arterial Hypertension","enrollment":30},{"nctId":"NCT00555087","phase":"PHASE4","title":"Treatment of Erectile Dysfunction in Hypogonadal Men With Testosterone Undecanoate","status":"UNKNOWN","sponsor":"Hospital Santa Fe","startDate":"2007-05","conditions":"Erectile Dysfunction, Hypogonadotrophic Males","enrollment":50}],"_emaApprovals":[],"_faersSignals":[{"count":1562,"reaction":"ERECTILE DYSFUNCTION"},{"count":1279,"reaction":"DRUG INEFFECTIVE"},{"count":702,"reaction":"HEADACHE"},{"count":327,"reaction":"FLUSHING"},{"count":234,"reaction":"DIZZINESS"},{"count":222,"reaction":"ERECTION INCREASED"},{"count":220,"reaction":"NASAL CONGESTION"},{"count":180,"reaction":"CHRONIC KIDNEY DISEASE"},{"count":166,"reaction":"ADVERSE EVENT"},{"count":163,"reaction":"NAUSEA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL1339"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":121,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Levitra","genericName":"Levitra","companyName":"Rabin Medical Center","companyId":"rabin-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:40:55.513425+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}